Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.

ABSTRACT:

Background

Totally implantable vascular access device (TIVAD)-related complications interfere in the anticancer treatment and increase medical expenses. We examined whether the implantation side of central line TIVADs is associated with the occurrence of thrombotic or occlusion events.

Methods

We enrolled patients with cancer who required central line TIVADs and randomised them to receive the TIVAD implantation on either the left or right side. The primary endpoint was the occurrence of catheter-related thrombotic or occlusion events.

Results

We randomised 240 patients, of which 235 received TIVAD implantation according to the protocol. In the per-protocol cohort, 117 and 118 patients received implantation on the left and right sides, respectively. Catheter-related th

SUBMITTER: Lin WY 

PROVIDER: S-EPMC5625671 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature